4-Hydroxytamoxifen

Alternative names

Atherosclerosis, susceptibility to, included, DKFZp686N23123, DKFZp781L1617, ER, ER-alpha, ER-beta, ERR B2, ERR G2, ERR a, ERR b, ERR beta-2, ERR gamma-2, ERR-alpha, ERR-beta, ERR1 protein, ERR1_HUMAN, ERR2_HUMAN, ERR3_HUMAN, ERRgamma, ER[a], ER[b], ESR, ESR B, ESR BETA, ESR L2, ESR1_HUMAN, ESR2_HUMAN, ESRA, ESRL 1, ESRR A, ESRRG, ESTR B, Era, Erb, Erb2, Esrrb, Estr, Estra, Estradiol Receptor alpha, Estradiol Receptor beta, Estradiol receptor, Estrogen Receptor 1, Estrogen Receptor 2, Estrogen receptor, Estrogen receptor 1 (alpha), Estrogen receptor 2 (ER beta), Estrogen receptor 2 ER beta, Estrogen receptor alpha, Estrogen receptor beta, Estrogen receptor beta 4, Estrogen receptor related 1, Estrogen receptor related 2, Estrogen receptor-like 1, Estrogen receptor-like 2, Estrogen receptor-related protein 3, Estrogen resistance, included, Estrogen-related receptor alpha, Estrogen-related receptor beta, Estrogen-related receptor gamma, Estrra, Estrrb, FLJ16023, HDL cholesterol, augmented response of, to hormone replacement, included, KIAA0832, Myocardial infarction, susceptibility to, included, NR3A1, NR3A2, NR3B1, NR3B3, Nr3b2, Nuclear receptor ERRB2, Nuclear receptor subfamily 3 group A member 1, Nuclear receptor subfamily 3 group A member 2, Nuclear receptor subfamily 3 group B member 1, Nuclear receptor subfamily 3 group B member 2, Nuclear receptor subfamily 3 group B member 3, OTTHUMP00000017718, OTTHUMP00000017719, Orphan nuclear receptor, RNESTROR, Steroid hormone receptor ERR 2, Steroid hormone receptor ERR1, estrogen nuclear receptor beta variant a, estrogen nuclear receptor beta variant b, estrogen receptor related receptor alpha, hERR1